Page last updated: 2024-12-06

methoxine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methoxine: oxa-analog of methionine; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18713
SCHEMBL ID524526
MeSH IDM0114274

Synonyms (28)

Synonym
4385-91-5
butyric acid, 2-amino-4-methoxy-
methoxine
a 7572
nsc-9325
homoserine, o-methyl-
nsc9325
methoxinine
AKOS000195201
2-amino-4-methoxybutanoic acid
2-amino-4-methoxy-butyric acid
EN300-62236
einecs 224-496-5
2-amino-4-methoxybutyric acid
nsc 9325
butyric acid, 2-amino-4-methoxy-, dl-
o-methylhomoserine
dl-2-amino-4-methoxybutanoic acid
oxymethionine
AKOS022482961
SCHEMBL524526
KFHRMMHGGBCRIV-UHFFFAOYSA-N
gamma-methoxy-alpha-amino butyric acid
F8887-3926
DTXSID40884068
STARBLD0013336
CS-0065907
Z317025018
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (62.50)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.21 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]